GLIPR1 Antikörper (Internal Region)
Kurzübersicht für GLIPR1 Antikörper (Internal Region) (ABIN238634)
Target
Alle GLIPR1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Bindungsspezifität
- Internal Region
-
Verwendungszweck
- GLIPR1 / RTVP-1
-
Sequenz
- NRQRDQVKRY YS
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Immunogen
- Peptide with sequence C-NRQRDQVKRYYS, from the internal region of the protein sequence according to NP_006842.2.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Western Blot: Preliminary experiments gave an approx 40 kDa band in human prostate lysates after 1 μg/mL antibody staining. Please note that currently we cannot find an explanation in the literature for the band we observe given the calculated size of 30.4
Peptide ELISA: antibody detection limit dilution 1:64000.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- GLIPR1 (GLI Pathogenesis-Related 1 (GLIPR1))
-
Andere Bezeichnung
- GLIPR1
-
Hintergrund
- GLIPR1, GLI pathogenesis-related 1 (glioma), RTVP-1, CRISP7, GLIPR, RTVP1, glioma pathogenesis-related protein, glioma pathogenesis-related protein 1, related to testis-specific, vespid, and pathogenesis proteins 1, testes-specific vespid and pathogenesis
-
Gen-ID
- 11010
-
NCBI Accession
- NP_006842
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Target
-